Federal Register / Vol. 71, No.

143 / Wednesday, July 26, 2006 / Notices 42405

TABLE I—Continued
Approximate Application due Approx. grant
States/populations/areas to be served funding available date funding date

Region IX:
Navajo Nation ........................................................................................................... 640,000 03/01/07 07/01/07
Commonwealth of the Northern Mariana Islands .................................................... 170,000 09/01/06 01/01/07
Federated States of Micronesia ............................................................................... 411,000 03/01/07 07/01/07
Nevada, Washoe County ......................................................................................... 708,000 03/01/07 07/01/07
Region X:
Alaska ....................................................................................................................... 420,000 03/01/07 07/01/07
Oregon ...................................................................................................................... 2,452,000 03/01/07 07/01/07
Idaho ......................................................................................................................... 1,568,000 03/01/07 07/01/07
Washington ............................................................................................................... 3,240,000 09/01/06 01/01/07
Washington, Seattle area ......................................................................................... 159,000 03/01/07 07/01/07

Dated: July 19, 2006. DEPARTMENT OF HEALTH AND 8456, e-mail

Evelyn M. Kappeler, HUMAN SERVICES jholmberg@osophs.dhhs.gov.
Acting Director, Office of Population Affairs. SUPPLEMENTARY INFORMATION: Public
Meeting of the Advisory Committee on
[FR Doc. E6–11963 Filed 7–25–06; 8:45 am] comment will be solicited at the
Blood Safety and Availability
BILLING CODE 4150–34–P meeting and will be limited to five
AGENCY: Office of Public Health and minutes per speaker. Individuals who
Science, Office of the Secretary, DHHS. wish to present comments to the
DEPARTMENT OF HEALTH AND ACTION: Notice. Committee should contact the Executive
HUMAN SERVICES Secretary to register no later than close
SUMMARY: As stipulated by the Federal of business on August 25, 2006.
Office of the National Coordinator; Advisory Committee Act, the U.S. Individuals who wish to have printed
American Health Information Department of Health and Human material distributed are encouraged to
Community Biosurveillance Data Services is hereby giving notice that the provide thirty (30) copies to the
Steering Group Meeting Advisory Committee on Blood Safety Executive Secretary no later than close
and Availability (ACBSA) will hold a of business August 25, 2006. Likewise,
meeting. The ACBSA will meet to those who wish to utilize electronic data
ACTION: Announcement of meeting. review progress and solicit additional projection to the Committee must
input regarding numerous submit their materials to the Executive
SUMMARY: This notice announces the recommendations made during the past
third meeting of the American Health Secretary prior to close of business
year, specifically biovigilance of blood August 25, 2006.
Information Community Biosurveillance components and its derivatives, cells,
Data Steering Group in accordance with tissues, and organs. Vigilance is Dated: July 20, 2006.
the Federal Advisory Committee Act recognized as a necessary step in Jerry A. Holmberg,
(Pub. L. No. 92–463, 5 U.S.C., App.). monitoring outcomes in a quality Executive Secretary, Advisory Committee on
assurance process toward the goal of Blood Safety and Availability.
DATES: August 8, 2006 from 2 p.m. to 4 [FR Doc. E6–11962 Filed 7–25–06; 8:45 am]
providing safe and available biological
p.m.
products (i.e., blood components and BILLING CODE 4150–41–P
ADDRESSES: Mary C. Switzer Building derivatives, cells, tissues and organs)
(330 C Street, SW., Washington, DC and improvement of care of the donor
20201), Conference Room 4090 (you and recipient. Elements necessary for DEPARTMENT OF HEALTH AND
will need a photo ID to enter a Federal vigilant surveillance are detection, HUMAN SERVICES
building). analysis, reporting, utilizations,
research, education, and management of Food and Drug Administration
FOR FURTHER INFORMATION CONTACT: outcomes, including emerging or re- [Docket No. 2006O–0231]
http://www.hhs.gov/healthit/ahic.html. emerging infectious and non-infectious
SUPPLEMENTARY INFORMATION: The events of transfusion and/or Over-the-Counter Drug Products;
meeting will be available via Internet transplantation, will be discussed. Safety and Efficacy Review; Additional
DATES: The meeting will take place Sunscreen Ingredient
access. Go to http://www.hhs.gov/
healthit/ahic.html for additional Wednesday, August 30 and Thursday, AGENCY: Food and Drug Administration,
information on the meeting. August 31, 2006 from 9 a.m. to 5 p.m. HHS.
ADDRESSES: Marriott Crystal Gateway,
Dated: July 19, 2006. ACTION: Notice of eligibility; request for
1700 Jeff Davis Highway, Arlington, VA data and information.
Judith Sparrow, 22202.
Director, American Health Information FOR FURTHER INFORMATION CONTACT: Jerry SUMMARY: The Food and Drug
Community, Office of Programs and A. Holmberg, PhD, Executive Secretary, Administration (FDA) is announcing a
Coordination, Office of the National Advisory Committee on Blood Safety call-for-data for safety and effectiveness
sroberts on PROD1PC70 with NOTICES

Coordinator for Health Information and Availability, Office of Public Health information on the following condition
Technology.
and Science, Department of Health and as part of FDA’s ongoing review of over-
[FR Doc. 06–6485 Filed 7–25–06; 8:45am] Human Services, 1101 Wootton the-counter (OTC) drug products:
BILLING CODE 4150–24–M Parkway, Room 250, Rockville, MD Diethylhexyl butamido triazone, up to 3
20852, (240) 453–8809, fax (240) 453– percent, as a sunscreen single active

VerDate Aug<31>2005 17:16 Jul 25, 2006 Jkt 208001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\26JYN1.SGM 26JYN1
 42406 Federal Register / Vol. 71, No. 143 / Wednesday, July 26, 2006 / Notices
ingredient and in combination with
other sunscreen active ingredients. FDA
reviewed a time and extent application
(TEA) for this condition and determined
that it is eligible for consideration in our
OTC drug monograph system. FDA will
evaluate the submitted data and
information to determine whether this
condition can be generally recognized as
safe and effective (GRASE) for its
proposed OTC use.
DATES: Submit data, information, and
general comments by October 24, 2006.
ADDRESSES: You may submit comments,
identified by Docket No. 2006O–0231,
by any of the following methods:
Electronic Submissions
Submit electronic comments in the
following ways:
• Federal eRulemaking Portal: http://
www.regulations.gov. Follow the
instructions for submitting comments.
• Agency Web site: http://
www.fda.gov/dockets/ecomments.
Follow the instructions for submitting
comments on the agency Web site.
Written Submissions
Submit written submissions in the
following ways:
• FAX: 301–827–6870.
• Mail/Hand delivery/Courier [For
paper, disk, or CD–ROM submissions]:
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
To ensure more timely processing of
comments, FDA is no longer accepting
comments submitted to the agency by e-
mail. FDA encourages you to continue
to submit electronic comments by using
the Federal eRulemaking Portal or the
agency Web site, as described in the
Electronic Submissions portion of this
paragraph.
Instructions: All submissions received
must include the agency name and
Docket number for this rulemaking. All
comments received may be posted
without change to http://www.fda.gov/
ohrms/dockets/default.htm, including
any personal information provided. For
additional information on submitting
comments, see the ‘‘Request for
Comments, Data, and Information’’
heading of the SUPPLEMENTARY
INFORMATION section of this document.
Docket: For access to the docket to
read background documents or
comments received, go to http://
www.fda.gov/ohrms/dockets/
default.htm and insert the docket
number, found in brackets in the
sroberts on PROD1PC70 with NOTICES
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
VerDate Aug<31>2005 17:16 Jul 25, 2006 Jkt 208001
FOR FURTHER INFORMATION CONTACT:
Michael L. Koenig, Center for Drug
Evaluation and Research (mail stop
5411), Food and Drug Administration,
bldg. 22, 10903 New Hampshire Ave.,
Silver Spring, MD 20993–0002, 301–
796–2090.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of January 23,
2002 (67 FR 3060), FDA published a
final rule establishing criteria and
procedures for additional conditions to
become eligible for consideration in the
OTC drug monograph system. These
criteria and procedures, codified in
§ 330.14 (21 CFR 330.14), permit OTC
drugs initially marketed in the United
States after the OTC drug review began
in 1972 and OTC drugs without any
marketing experience in the United
States to become eligible for FDA’s OTC
drug monograph system. The term
‘‘condition’’ means an active ingredient
or botanical drug substance (or a
combination of active ingredients or
botanical drug substances), dosage form,
dosage strength, or route of
administration, marketed for a specific
OTC use (§ 330.14(a)). The criteria and
procedures also permit conditions that
are regulated as cosmetics or dietary
supplements in foreign countries but
that would be regulated as OTC drugs in
the United States to become eligible for
the OTC drug monograph system.
Sponsors must provide specific data
and information in a TEA to
demonstrate that the condition has been
marketed for a material time and to a
material extent to become eligible for
consideration in the OTC drug
monograph system. When the condition
is found eligible, FDA publishes a
notice of eligibility and request for
safety and effectiveness data for the
proposed OTC use. The TEA that FDA
reviewed (Ref. 1) and FDA’s evaluation
of the TEA (Ref. 2) have been placed on
public display in the Division of
Dockets Management (see ADDRESSES)
under the docket number found in
brackets in the heading of this
document. Information deemed
confidential under 18 U.S.C. 1905, 5
U.S.C. 552(b), or 21 U.S.C. 331(j)
(section 301(j) of the Federal Food,
Drug, and Cosmetic Act) was deleted
from the TEA before it was placed on
public display.
II. Request for Comments, Data, and
Information
FDA determined that the information
submitted in this TEA satisfies the
criteria of § 330.14(b). FDA will evaluate
diethylhexyl butamido triazone, up to 3
percent, as a sunscreen single active
PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\26JYN1.SGM
ingredient and in combination with
other existing monograph sunscreen
active ingredients, for inclusion in the
monograph for OTC sunscreen drug
products (part 352 (21 CFR part 352)).
Accordingly, FDA invites all interested
persons to submit data and information,
as described in § 330.14(f), on the safety
and effectiveness of this active
ingredient for this use so that FDA can
determine whether it can be GRASE and
not misbranded under recommended
conditions of OTC use. Additional data
should be included to establish the
safety and effectiveness of sunscreen
drug products containing a combination
of diethylhexyl butamido triazone with
other existing sunscreen monograph
active ingredients in § 352.10.
The TEA did not include an official
or proposed United States
Pharmacopeia-National Formulary
(USP–NF) drug monograph for
diethylhexyl butamido triazone.
According to § 330.14(i), sponsors must
include an official or proposed USP–NF
monograph as part of the safety and
effectiveness data for this ingredient.
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments, data, and information.
Submit three copies of all comments,
data, and information. Individuals
submitting written information or
anyone submitting electronic comments
may submit one copy. Submissions are
to be identified with the docket number
found in brackets in the heading of this
document and may be accompanied by
supporting information. Received
submissions may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Information submitted after the closing
date will not be considered except by
petition under 21 CFR 10.30.
III. Marketing Policy
Under § 330.14(h), any product
containing the condition for which data
and information are requested may not
be marketed as an OTC drug in the
United States at this time unless it is the
subject of an approved new drug
application or abbreviated new drug
application.
IV. References
The following references are on
display in the Division of Dockets
Management (see ADDRESSES) and may
be seen by interested persons between 9
a.m. and 4 p.m., Monday through
Friday.
1. TEA for diethylhexyl butamido triazone
submitted by 3V, Inc., on September 16,
2005.
26JYN1
 Federal Register / Vol. 71, No. 143 / Wednesday, July 26, 2006 / Notices
2. FDA’s evaluation and comments on the
TEA for diethylhexyl butamido triazone.
Dated: July 14, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–11874 Filed 7–25–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Aviation Security Advisory Committee
Meeting
AGENCY: Transportation Security
Administration (TSA), DHS.
ACTION: Notice of meeting.
SUMMARY: This notice announces a
telephonic meeting of the Aviation
Security Advisory Committee (ASAC).
DATES: The meeting will take place on
August 16, 2006, from 2:30 p.m. to 3:30
p.m., Eastern time.
ADDRESSES: The meeting will be held by
telephonic conference call. Dial-in
instructions are set forth in the
SUPPLEMENTARY INFORMATION section
below.
FOR FURTHER INFORMATION CONTACT:
Richard Swigart, Office of
Transportation Sector Network
Management (TSA–28), TSA
Headquarters, 601 South 12th Street,
Arlington, VA 22202; telephone 571–
227–3719, e-mail
richard.swigart@dhs.gov.
SUPPLEMENTARY INFORMATION: This
meeting is announced pursuant to
section 10(a)(2) of the Federal Advisory
Committee Act, as amended (5 U.S.C.
App.). The agenda for the meeting will
include presentation of the report and
recommendations of the Baggage
Screening Investment Study (BSIS)
working group.
This meeting, from 2:30 p.m. to 3:30
p.m., is open to the public but
telephonic conferencing capacity is
limited. Members of the public who
wish to monitor the discussion may dial
into this telephonic meeting by dialing
(800) 988–9352. At the prompt, provide
the conference code ‘‘ASAC’’
(pronounced ‘‘A-sack’’). Parties calling
from locations outside the United States
must contact the person listed under the
heading FOR FURTHER INFORMATION
CONTACT, for international calling
instructions.
sroberts on PROD1PC70 with NOTICES
Persons desiring a copy of the
working group’s report may request it by
contacting the person listed under the
heading FOR FURTHER INFORMATION
CONTACT.
VerDate Aug<31>2005 17:16 Jul 25, 2006 Jkt 208001
Members of the public must make
advance arrangements to present oral
statements at this ASAC meeting.
Written statements may be presented to
the committee by providing copies of
them to the Chair prior to the meeting.
Comments may be sent to the person
listed under the heading FOR FURTHER
INFORMATION CONTACT. Anyone in need
of assistance or a reasonable
accommodation for the meeting should
contact the person listed under the
heading FOR FURTHER INFORMATION
CONTACT.
Issued in Arlington, Virginia, on July 21,
2006.
John Sammon,
Assistant Administrator for Transportation
Sector Network Management.
[FR Doc. E6–11935 Filed 7–25–06; 8:45 am]
BILLING CODE 9110–05–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
[Docket No. TSA–2006–25335]
RIN 1652–ZA08 [Corrected]
Privacy Act of 1974: System of
Records; National Finance Center
(NFC) Payroll Personnel System;
Correction
AGENCY: Transportation Security
Administration, DHS.
ACTION: Notice to establish a new system
of records; request for comments;
correction.
SUMMARY: This document makes a
correction to the notice published in the
Federal Register on July 17, 2006,
establishing a new system of records
under the Privacy Act of 1974. The new
system is known as the National
Finance Center Payroll Personnel
System (DHS/TSA 022) and is to be
used to reflect the Transportation
Security Administration’s (TSA)
migration from its legacy payroll system
(the Department of Transportation’s
Integrated Personnel and Payroll System
(IPPS), Consolidated Uniform Payroll
System (CUPS), and Consolidated
Personnel Management Information
System (CPMIS)) to the Department of
Agriculture’s National Finance Center
(NFC). TSA inadvertently transposed
the digits in the RIN number in the
document headings section. This
document corrects this number.
DATES: Effective July 26, 2006.
FOR FURTHER INFORMATION CONTACT:
Marisa Mullen, Office of the Chief
Counsel (Regulations), TSA–2,
Transportation Security Administration,
PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\26JYN1.SGM
42407
601 South 12th Street, Arlington, VA
22202–4220; telephone (571) 227–2706.
SUPPLEMENTARY INFORMATION:
Background
On July 17, 2006, TSA published a
notice in the Federal Register (71 FR
40530), establishing a new system of
records under the Privacy Act of 1974,
known as the National Finance Center
Payroll Personnel System (DHS/TSA
022). TSA inadvertently transposed the
digits in the RIN number in the
document headings section. This
document corrects this number from
RIN 1652–AZ08 to RIN 1652–ZA08.
Correction
In notice FR Doc. E6–11235,
published on July 17, 2006 (71 FR
40530), make the following correction:
On page 40530, column one, line five,
in the document headings section,
remove the words ‘‘RIN 1652–AZ08’’
and add in its place the words ‘‘RIN
1652–ZA08’’.
Issued in Arlington, Virginia, on July 19,
2006.
Mardi Ruth Thompson,
Deputy Chief Counsel for Regulations.
[FR Doc. E6–11903 Filed 7–25–06; 8:45 am]
BILLING CODE 9110–05–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Extension of a Currently
Approved Information Collection;
Comment Request
ACTION: 60-day notice of information
collection under review: Interagency
Record of Individual Requesting
Change/Adjustment To or From A or G
Status or Requesting A, G, or NATO
Dependent Employment Authorization;
Form I–566, OMB Control Number
1615–0027.
The Department of Homeland
Security, U.S. Citizenship and
Immigration Services has submitted the
following information collection request
for review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted for
sixty days until September 25, 2006.
Written comments and/or suggestions
regarding the item(s) contained in this
notice, especially regarding the
estimated public burden and associated
26JYN1